ผลงานวิจัยตีพิมพ์ปี 2014

1. Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms

Akkarathamrongsin, S., Payungporn, S., Thong, V.D., Poovorawan, K., Prapunwattana, P., Poovorawan, Y., Tangkijvanich, P.

World Journal of Gastroenterology.2014;20(30):10599-10605.

2. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6

Akkarathamrongsin, S., Thong, V.D., Payungporn, S., Poovorawan, K., Prapunwattana, P., Poovorawan, Y., Tangkijvanich, P.

Journal of Medical Virology.2014;86(9):1482-1490.

3. Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy

Crane, M., Avihingsanon, A., Rajasuriar, R., Velayudham, P., Iser, D., Solomon, A., Sebolao, B., Tran, A., Spelman, T., Matthews, G., Cameron, P., Tangkijvanich, P., Dore, G.J., Ruxrungtham, K., Lewin, S.R.

Journal of Infectious Diseases. 2014;210(5):745-751.

4. Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in Thai population

Posuwan, N., Payungporn, S., Tangkijvanich, P., Ogawa, S., Murakami, S., Iijima, S., Matsuura, K., Shinkai, N., Watanabe, T., Poovorawan, Y., Tanaka, Y.

PLoS ONE.2014;9(1):art. no. e86007 .

5. Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels

Avihingsanon, A., Jitmitraparp, S., Tangkijvanich, P., Ramautarsing, R.A., Apornpong, T., Jirajariyavej, S., Putcharoen, O., Treeprasertsuk, S., Akkarathamrongsin, S., Poovorawan, Y., Matthews, G.V., Lange, J.M., Ruxrungtham, K.

Journal of Gastroenterology and Hepatology (Australia). 2014;29(9):1706-1714.

6. Correlation of HBsAg titers with serum fibrotic maker in patients with chronic hepatitis B infection.

Poovorawan, K., Treeprasertsuk, S., Tangkijvanich, P., Komolmit, P., Poovorawan, Y.

The Southeast Asian journal of tropical medicine and public health.2014;45(3):630-635.

7. Hepatitis C virus genotype 6: Virology, epidemiology, genetic variation and clinical implication

Thong, V.D., Akkarathamrongsin, S., Poovorawan, K., Tangkijvanich, P., Poovorawan, Y.

World Journal of Gastroenterology.2014;20(11):2927-2940.

8. Risk factors and molecular characterization of acute sporadic symptomatic hepatitis E virus infection in Thailand

Poovorawan, K., Jitmitrapab, S., Treeprasertsuk, S., Thongmee, T., Theamboonlers, A., Tangkijvanich, P., Komolmit, P., Poovorawan, Y.

Asian Pacific Journal of Tropical Medicine.2014;7(9):709-714.

9. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy

Avihingsanon, A., Apornpong, T., Ramautarsing, R.A., Ubolyam, S., Tangkijvanich, P., Ananworanich, J., Lange, J.M.A., Matthews, G., Lewin, S.R., Ruxrungtham, K.

Antiviral Therapy.2014;19(1):41-49.

ผลงานวิจัยตีพิมพ์ปี 2013

1. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).

Chittmittrapap S, Chieochansin T, Chaiteerakij R, Treeprasertsuk S, KlaikaewN, Tangkijvanich P, Komolmit P, Poovorawan Y.

Asian Pac J Cancer Prev. 2013;14(12):7675-9. PubMed PMID: 24460352.

2. Circulating cytokines and histological liver damage in chronic hepatitis B infection.

Poovorawan K, Tangkijvanich P, Chirathaworn C, Wisedopas N, Treeprasertsuk S, Komolmit P, Poovorawan Y.

Hepat Res Treat. 2013;2013:757246. doi:10.1155/2013/757246. Epub 2013 Oct 31. PubMed PMID: 24288603; PubMed CentralPMCID: PMC3833406.

3. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy.

Avihingsanon A, Apornpong T, Ramautarsing RA, Ubolyam S, Tangkijvanich P,Ananworanich J, Lange JM, Matthews G, Lewin SR, Ruxrungtham K; HIV-NAT 105 study team.

AntivirTher. 2014;19(1):41-9. doi:10.3851/IMP2673. Epub 2013 Aug 23. PubMed PMID: 23970149.

Can't download pdf file

4. Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b.

Kuakarn S, SomParn P, Tangkijvanich P, Mahachai V, Thongboonkerd V, Hirankarn N.

World J Gastroenterol. 2013 Aug 21;19(31):5067-75. doi:10.3748/wjg.v19.i31.5067. PubMed PMID: 23964140; PubMed Central PMCID:PMC3746378.

5. Comparison of long-term outcome of patients with Wilson's disease presenting with acute liver failure versus acute-on-chronic liver failure.

Thanapirom K, Treeprasertsuk S, Komolmit P, Tangkijvanich P, Kullavanijaya P.

J Med Assoc Thai. 2013Feb;96(2):150-6. PubMed PMID: 23936979.

6. Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection.

Chalermchai T, Hiransuthikul N, Tangkijvanich P, Pinyakorn S, Avihingsanon A,Ananworanich J.

AIDS Res Ther. 2013 Jul26;10:21. doi: 10.1186/1742-6405-10-21. eCollection 2013. PubMed PMID: 23885958; PubMed Central PMCID: PMC3727961.

7. Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand.

Akkarathamrongsin S, Hacharoen P, Tangkijvanich P, Theamboonlers A, Tanaka Y,Mizokami M, Poovorawan Y.

Intervirology. 2013;56(5):284-94. doi: 10.1159/000351621. Epub 2013 Jul 3. PubMed PMID: 23838334.

8. The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients.

Sopipong W, Tangkijvanich P, Payungporn S, Posuwan N, Poovorawan Y.

Asian Pac JCancer Prev. 2013;14(5):2865-9. PubMed PMID: 23803045.

9. Association of interferon-alpha gene polymorphisms with chronic hepatitis B virus infection. Kimkong I, Tangkijvanich P, Hirankarn N.

Int J Immunogenet. 2013Dec;40(6):476-81. doi: 10.1111/iji.12055. Epub 2013 Apr 8. PubMed PMID: 23566196.

10. Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencing.

Tangkijvanich P, Sa-Nguanmoo P, Avihingsanon A, Ruxrungtham K, Poovorawan K, Poovorawan Y.

J Med Virol. 2013 Jan;85(1):16-25. doi: 10.1002/jmv.23430. Epub 2012 Sep 28. PubMedPMID: 23024025.

11. Association of IFNAR2 and IL10RB genes in chronic hepatitis B virus infection.

Romporn S, Hirankarn N, Tangkijvanich P, Kimkong I.

Tissue Antigens. 2013Jul;82(1):21-5. doi: 10.1111/tan.12133. PubMed PMID: 23745570.

12. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.

Thongbai C, Sa-nguanmoo P, Kranokpiruk P, Poovorawan K, Poovorawan Y,Tangkijvanich P.

Asian Pac J Cancer Prev.2013;14(6):3555-9. PubMed PMID: 23886144.

13. Diagnostic accuracy of liver stiffness measurement and serum hyaluronic acid for detecting liver fibrosis in chronic hepatitis B with respect to ALT levels.

Kongtawelert, P., Chanmee, T., Pothacharoen, P., Wisedopa, N., Kranokpiruk, P., Poovorawan, K., Poovorawan, Y., Tangkijvanich, P.

Asian Biomedicine. 2013;7(5):609-617.

Can't download pdf file
ผลงานวิจัยตีพิมพ์ปี 2008-2012

1. Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencing .

Tangkijvanich P, Sa-Nguanmoo P, Avihingsanon A, Ruxrungtham K, Poovorawan K, Poovorawan Y.

J Med Virol. 2013 Jan; 85(1):16-25.

2. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: A case-control study in Thailand .

Sa-Nguanmoo P, Tangkijvanich P, Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Thawornsuk N, Theamboonlers A, Poovorawan Y.

J Med Virol. 2012 Aug; 84(8):1177-85.

3. Response-guided therapy for patients with hepatitis C virus genotype 6 infection: A pilot study .

Tangkijvanich P, Komolmit P, Mahachai V, Poovorawan K, Akkarathamrongsin S, Poovorawan Y.

J Viral Hepat. 2012 Jun; 19(6):423-30.

4. Hepatitis B and hepatitis C virus in Thai blood donors.

Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2011 May; 42(3):609-15. Review.

5. Hepatitis B among pregnant women attending health care facilities in rural Bangladesh.

Shamsuzzaman M, Singhasivanon P, Kaewkungwal J, Lawpoolsri S, Tangkijvanich P, Gibbons RV, Rahman M, Alamgir AS, Mahtab MA.

Southeast Asian J Trop Med Public Health. 2011 Nov; 42(6):1410-3.

6. Seroprevalence and genotype of Hepatitis C virus among immigrant workers from Cambodia and Myanmar in Thailand .

Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Poovorawan Y.

Intervirology. 2011 ; 54(1):10-6.

7. A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma .

Tangkijvanich P, Sa-Nguanmoo P, Mahachai V, Theamboonlers A, Poovorawan Y.

Hepatol Int. 2010 Jul 31 ; 4(3):577-84.

8. Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand .

Sa-Nguanmoo P, Tangkijvanich P, Thawornsuk N, Vichaiwattana P, Prianantathavorn K, Theamboonlers A, Tanaka Y, Poovorawan Y.

J Med Virol. 2010 Aug; 82(8):1341-9.

9. Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon- a - 2 b therapy in hepatitis B e-antigen-positive chronic hepatitis B .

Tangkijvanich P, Komolmit P, Mahachai V, Sa-Nguanmoo P, Theamboonlers A, Poovorawan Y.

Hepatol Res. 2010 Apr; 40(4):269-77.

10. Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand .

Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y.

J Med Virol. 2010 Feb; 82(2):257-62.

11. Diagnostic role of serum glypican- 3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers .

Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.

J Gastroenterol Hepatol. 2010 Jan; 25(1):129-37.

12. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha- 2 b therapy in chronic hepatitis B .

Tangkijvanich P, Komolmit P, Mahachai V, Sa-nguanmoo P, Theamboonlers A, Poovorawan Y.

J Clin Virol. 2009 Oct; 46(2):117-23.

13. Prevalence, whole genome characterization and phylogenetic analysis of hepatitis B virus in captive orangutan and gibbon .

Sa-nguanmoo P, Thongmee C, Ratanakorn P, Pattanarangsan R, Boonyarittichaikij R, Chodapisitkul S, Theamboonlers A, Tangkijvanich P, Poovorawan Y.

J Med Primatol. 2008 Dec; 37(6):277-89.

14. Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre-S and S genes .

Suwannakarn K, Tangkijvanich P, Thawornsuk N, Theamboonlers A, Tharmaphornpilas P, Yoocharoen P, Chongsrisawat V, Poovorawan Y.

Hepatol Res. 2008 Mar; 38(3):244-51.